By Fineline Cube Neusoft Medical Systems Co., Ltd, a leading player in the medical technology sector, has announced that its radiotherapy unit, Neusoft Ruizhi Radiotherapy Technology Co., Ltd, has received marketing approval from the National Medical Products Administration (NMPA) for the high-end medical linear accelerator, NeuRT Aurora intelligent radiotherapy platform. This approval marks a significant advancement in the field of radiotherapy solutions in China.
Innovative Radiotherapy Capabilities
The NeuRT Aurora platform is capable of supporting the world’s first spiral volume modulated (SVMAT) treatment, a groundbreaking technology that combines the benefits of tomotherapy (TOMO) and volume rotation modulated (VMAT) techniques. This innovative approach to radiotherapy allows for superior dose distribution and improved protection of healthy organs, enhancing the overall therapeutic efficacy for patients undergoing cancer treatment.
Enhancing Cancer Treatment Outcomes
The integration of SVMAT in the NeuRT Aurora platform signifies a leap forward in the precision and effectiveness of radiotherapy. By optimizing dose delivery and minimizing damage to surrounding tissues, the platform contributes to better patient outcomes and improved quality of life for those battling cancer.-Fineline Info & Tech